StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
237880.KQ$10840.00-0.64%
Fair $10840.00+0.0%

237880.KQ

CLIO Cosmetics Co.,Ltd

Consumer Defensive / Household & Personal ProductsKOSDAQ

$10840.00

-70.00 (-0.64%)

Fairly Valued+0.0%Fair Value $10840.00Fund rank 31/100 · Data gapFallback financials|
SA 47/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 24%

FCF escenarios

weak_data · normalized FCF $16.6B · quality 59.0/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 38/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

47/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 237880.KQLocal privado en este navegador · CLIO Cosmetics Co.,Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$190.0B

P/E

14.4x

↓

EV/EBITDA

5.3x

↓

ROE

5.6%

↓

Gross Margin

49.1%

↑

Debt/Equity

0.01

↓
52-Week Range$10840
$10400$17150

TradingView lightweight chart

237880.KQ price, volumen y niveles de valoración

Último $10,840Periodo -70.5%
Fair value: $10,840

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+6.5%

FCF CAGR

—

FCF margin

3.8%

FCF / Net income

0.92x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $328.90B · net income $13.56B · FCF $12.47B

2022-FY → 2025-FY

Gross margin

49.1%-0.4% pts

Operating margin

5.0%-1.6% pts

Net margin

4.1%+0.4% pts

FCF margin

3.8%+4.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$328.90B$328.90B$351.37B$330.58B$272.46B
Net Income$13.56B$13.56B$27.86B$27.70B$10.13B
EBITDA$18.45B$18.45B$35.02B$38.71B$18.98B
EPS755.00755.001550.001560.00584.00
Gross Margin49.1%49.1%48.8%50.2%49.5%
Operating Margin5.0%5.0%7.0%10.2%6.6%
Net Margin4.1%4.1%7.9%8.4%3.7%
Balance Sheet
Debt/Equity0.010.010.010.010.00
Current Ratio3.353.35———
Cash Flow
Free Cash Flow$12.47B$12.47B$16.59B$34.86B$-1.42B
Returns
ROE5.6%5.6%11.9%13.0%5.3%
Valuation
P/E14.3614.3611.4319.5829.11
EV/EBITDA5.275.275.9912.9813.23
P/B0.800.801.362.541.55
Growth & Yield
Revenue Growth-6.4%-6.4%6.3%21.3%—
EPS Growth-51.3%-51.3%-0.6%167.1%—
Dividend Yield2.3%2.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

8.4%

razonable

EPS terminal req.

$961.87

Spread vs growth

-59.7%

5Y implied EPS CAGR

9.0%

razonable

EPS terminal req.

$1163.86

Spread vs growth

-60.3%

10Y implied EPS CAGR

9.5%

razonable

EPS terminal req.

$1874.41

Spread vs growth

-60.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -28.8%

Total return

-28.8%

Start / end P/E

10.2x → 14.4x

EPS bridge

1550.00 → 755.00

Residual

-21.2%

EPS growth-51.3%
Multiple rerating+41.4%
Dividend+2.3%
Residual / FX / buybacks / cross-term-21.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.